Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy.
OBJECTIVE:To determine if a commercial myostatin reducer (Fortetropin®) would inhibit disuse muscle atrophy in dogs after a tibial plateau leveling osteotomy. DESIGN:A prospective randomized, double-blinded, placebo-controlled clinical trial. ANIMALS:One hundred client-owned dogs presenting for surg...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231306 |